| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.9.1.109 |
| P698 | PubMed publication ID | 2643421 |
| P2093 | author name string | Bini A | |
| Fenoglio JJ Jr | |||
| Mesa-Tejada R | |||
| Kaplan KL | |||
| Kudryk B | |||
| P433 | issue | 1 | |
| P921 | main subject | antibody | Q79460 |
| monoclonal antibody | Q422248 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 109-121 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Arteriosclerosis (Dallas, Tex.) | Q27709176 |
| P1476 | title | Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies | |
| P478 | volume | 9 |
| Q37268111 | A cerebrovascular perspective of atherosclerosis |
| Q24309485 | A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1 |
| Q41154373 | Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation |
| Q73764136 | An hydroalcoholic extract of Curcuma longa lowers the abnormally high values of human-plasma fibrinogen |
| Q36665512 | Angiogenesis in arteries: Review |
| Q41341898 | Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris |
| Q73940083 | Association of hemostatic factors with peripheral vascular disease |
| Q33843636 | C-reactive protein, inflammation, and coronary risk |
| Q79299389 | C-reactive protein, inflammation, and coronary risk |
| Q33686005 | Cellular adhesion molecules and atherogenesis |
| Q28565430 | Defibrinogenating effect of batroxobin (Defibrase) in rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin-treated rats in vitro |
| Q39357096 | Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen. |
| Q47765015 | Effect of crosslinking by factor XIIIa on the migration of vascular smooth muscle cells into fibrin gels |
| Q36614859 | Elevated D-dimer and fibrinogen levels in serum of preoperative bone fracture patients. |
| Q77808615 | Embolic risk based on aortic atherosclerotic morphologic features and aortic spontaneous echocardiographic contrast |
| Q74172963 | Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters |
| Q35848527 | FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis |
| Q35224492 | Fibrin and Its Derivatives in the Normal and Diseased Vessel Wall |
| Q34543467 | Fibrin precursors, intermediaries for hemostasis in the clot war. |
| Q72049303 | Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors |
| Q40409553 | Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia |
| Q37950860 | Fibrinogen as a key regulator of inflammation in disease |
| Q37379082 | Fibrinogen deficiency is compatible with the development of atherosclerosis in mice |
| Q74292655 | Fibrinogen in rat gastrointestinal lymph before, during and after intraduodenal administration of emulsified triglyceride: fibrinogen bound to chylomicrons in gastrointestinal lymph is functional |
| Q22254636 | Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival |
| Q73637155 | Fibrinogen is an efficient antioxidant |
| Q24322038 | Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway |
| Q78554580 | Fibrinogen-coated chylomicrons in gastrointestinal lymph: a new rationale regarding the arterial deposition of postprandial lipids |
| Q40406437 | Fibrinolysis and atherosclerosis |
| Q34998383 | Fibulin-1 and fibrinogen in human atherosclerotic lesions |
| Q41615867 | Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis |
| Q72465846 | Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface |
| Q37275036 | Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases |
| Q35832002 | Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas |
| Q34125013 | Increased platelet deposition on atherosclerotic coronary arteries |
| Q43872005 | Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease |
| Q40957917 | Intercellular adhesion molecule-1. |
| Q30479586 | Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading |
| Q35936616 | Lipoprotein oxidation products and arteriosclerosis: theory and methods with applicability to the clinical chemistry laboratory. |
| Q73096122 | Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects |
| Q73701444 | Localization and activity of tissue factor in human aortic atherosclerotic lesions |
| Q37581324 | Moderate rest intervals are superior to short intervals for improving PAI-1 following exhaustive exercise in recreational weightlifters |
| Q38162728 | Molecular MRI of atherosclerosis. |
| Q47761313 | Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence |
| Q34276269 | Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2receptor |
| Q40789887 | Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54). |
| Q40923118 | New approaches to the prevention of atherosclerosis |
| Q72024131 | Plasma macromolecular protein complex: Interaction with fibrin and fibrinolysis |
| Q72049376 | Plasminogen Activator Expression in Human Atherosclerotic Lesions |
| Q42566263 | Plasminogen and fibrinogen plasma levels in coronary artery disease |
| Q35803130 | Pro-inflammatory effect of fibrinogen on vascular smooth muscle cells by regulating the expression of PPARα, PPARγ and MMP-9 |
| Q36888651 | Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. |
| Q34626669 | Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. |
| Q74404156 | Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels |
| Q38215920 | Role of platelet inhibitor therapy in myocardial infarction |
| Q47963220 | Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads |
| Q49310158 | Sex difference in clot lysability and association to coronary artery calcification. |
| Q40656704 | Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3. |
| Q90634803 | Subendothelial matrix components influence endothelial cell apoptosis in vitro |
| Q43588751 | Suppressing thrombin generation is compatible with the development of atherosclerosis in mice |
| Q37211945 | The Porcine Model for the Understanding of Thrombogenesis and Atherogenesis |
| Q24298078 | The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity |
| Q36893444 | The hemostasis system in murine atherosclerosis |
| Q46466743 | The influence of type 2 diabetes on fibrin structure and function |
| Q71344128 | The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition |
| Q35181738 | The participation of leukocytes in coagulant reactions |
| Q33870602 | The role of plaque rupture and thrombosis in coronary artery disease |
| Q38737453 | Thrombosis in atherogenesis |
| Q59384963 | Timecourse of fibrin deposition and removal after arterial injury |
| Q33900126 | Tissue factor is rapidly induced in arterial smooth muscle after balloon injury |
| Q91768594 | Transferrin plays a central role in coagulation balance by interacting with clotting factors |
| Q36546041 | Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease |
| Q40925433 | Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies |
| Q74084731 | [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy] |
Search more.